In one significant study by Tanino et al., NICaS® was used to monitor chronic heart failure patients, and its derived parameters (SV and TPRI) were compared with conventional measures, including left ventricular ejection fraction (LVEF) and B-type natriuretic peptide (BNP) levels [6]. This evidence concerns the gene NPPB and congestive heart failure.